1887

Abstract

The influenza virus strains A/NT/60/68 and A/PR/8/34 both have an immunodominant D-restricted epitope in their nucleoprotein (NP) at amino acid residues 366–374, with two amino acid differences between the epitopes. Cross-reactive cytotoxic T lymphocytes (CTLs) were generated by priming mice with the influenza virus A/NT/60/68 NP and restimulating with influenza virus A/PR/8/34. CTLs that gave high levels of specific lysis recognized target cells infected with either strain of influenza virus with similar efficiency. Surprisingly, when target cells were infected with recombinant vaccinia viruses (VV) expressing the two different NPs, presentation of the D-restricted epitope from the A/NT/60/68 NP was extremely poor, whereas presentation of the equivalent epitope from the A/PR/8/34 NP was as efficient as in influenza virus-infected cells. This difference was observed in spite of the fact that the two NP sequences show 94% identity at the amino acid sequence level. Experiments with additional cross-reactive CTL cell lines which recognized target cells less efficiently revealed a similar difference in presentation between the two NP epitopes in influenza virus-infected cells and showed a difference in the efficiency of presentation of the D-restricted epitope from the two NP molecules independent of VV infection. The results show that two equivalent epitopes in highly similar proteins are processed with very different efficiency, even though they are both immunodominant epitopes. They also suggest that the previously described inhibition of antigen presentation by VV is a general, non-specific effect, which is more apparent for epitopes that are processed and presented less efficiently.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-5-1069
2001-05-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/5/0821069a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-5-1069&mimeType=html&fmt=ahah

References

  1. Antoine, G., Scheiflinger, F., Dorner, F. & Falkner, F. G. ( 1998; ). The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244, 365-396.[CrossRef]
    [Google Scholar]
  2. Anton, L. C., Yewdell, J. W. & Bennink, J. R. ( 1997; ). MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. Journal of Immunology 158, 2535-2542.
    [Google Scholar]
  3. Bennink, J. R. & Yewdell, J. W. ( 1990; ). Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Current Topics in Microbiology and Immunology 163, 153-184.
    [Google Scholar]
  4. Blake, N. W., Kettle, S., Law, K. M., Gould, K., Bastin, J., Townsend, A. R. M. & Smith, G. L. ( 1995; ). Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. Journal of General Virology 76, 2393-2398.[CrossRef]
    [Google Scholar]
  5. Cerundolo, V., Tse, A. G. D., Salter, R. D., Parham, P. & Townsend, A. ( 1991; ). CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1. Proceedings of the Royal Society of London Series B Biological Sciences 244, 169-177.[CrossRef]
    [Google Scholar]
  6. Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J. & Townsend, A. ( 1997; ). The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. European Journal of Immunology 27, 336-341.[CrossRef]
    [Google Scholar]
  7. Chakrabarti, S., Brechling, K. & Moss, B. ( 1985; ). Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5, 3403-3409.
    [Google Scholar]
  8. Cossins, J., Gould, K. G., Smith, M., Driscoll, P. & Brownlee, G. G. ( 1993; ). Precise prediction of a Kk-restricted cytotoxic T cell epitope within the NS1 protein of influenza virus using an MHC allele-specific motif. Virology 193, 289-295.[CrossRef]
    [Google Scholar]
  9. Coupar, B. E. H., Andrew, M. E., Both, G. W. & Boyle, D. B. ( 1986; ). Temporal regulation of influenza haemagglutinin expression in vaccinia virus recombinants and effects on the immune response. European Journal of Immunology 16, 1479-1487.[CrossRef]
    [Google Scholar]
  10. Gould, K. G., Scotney, H. & Brownlee, G. G. ( 1991; ). Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. Journal of Virology 65, 5401-5409.
    [Google Scholar]
  11. Haanen, J. B. A. G., Wolkers, M. C., Kruisbeek, A. M. & Schumacher, T. N. M. ( 1999; ). Selective expansion of cross-reactive CD8+ memory T cells by viral variants. Journal of Experimental Medicine 190, 1319-1328.[CrossRef]
    [Google Scholar]
  12. Hanke, T., Blanchard, T. J., Schneider, J., Ogg, G. S., Tan, R., Becker, M., Gilbert, S. C., Hill, A. V. S., Smith, G. L. & McMichael, A. ( 1998; ). Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. Journal of General Virology 79, 83-90.
    [Google Scholar]
  13. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. & Johnson, D. ( 1995; ). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.[CrossRef]
    [Google Scholar]
  14. Miller, D. M. & Sedmak, D. D. ( 1999; ). Viral effects on antigen processing. Current Opinion in Immunology 11, 94-99.[CrossRef]
    [Google Scholar]
  15. Moss, B. ( 1968; ). Inhibition of HeLa cell protein synthesis by the vaccinia virion. Journal of Virology 2, 1028-1037.
    [Google Scholar]
  16. Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L. & Hill, A. V. S. ( 1998; ). Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Medicine 4, 397-402.[CrossRef]
    [Google Scholar]
  17. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. & Bennink, J. R. ( 2000; ). Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770-774.[CrossRef]
    [Google Scholar]
  18. Smith, G. L., Levin, J. Z., Palese, P. & Moss, B. ( 1987; ). Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160, 336-345.[CrossRef]
    [Google Scholar]
  19. Smith, G. L., Howard, S. T. & Chan, Y. S. ( 1989; ). Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. Journal of General Virology 70, 2333-2343.[CrossRef]
    [Google Scholar]
  20. Tourdot, S., Oukka, M., Manuguerra, J. C., Magafa, V., Vergnon, I., Riche, N., Bruley-Rosset, M., Cordopatis, P. & Kosmatopoulos, K. ( 1997; ). Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity. Journal of Immunology 159, 2391-2398.
    [Google Scholar]
  21. Townsend, A. R. M., McMichael, A. J., Carter, N. P., Huddleston, J. A. & Brownlee, G. G. ( 1984; ). Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39, 13-25.[CrossRef]
    [Google Scholar]
  22. Townsend, A. R. M., Gotch, F. M. & Davey, J. ( 1985; ). Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42, 457-467.[CrossRef]
    [Google Scholar]
  23. Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S. & Smith, G. ( 1988; ). Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168, 1211-1224.[CrossRef]
    [Google Scholar]
  24. Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J. & Ploegh, H. L. ( 1996; ). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-5-1069
Loading
/content/journal/jgv/10.1099/0022-1317-82-5-1069
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error